These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18067920)

  • 1. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.
    Wang T; Tian C; Zhang W; Sarkis PT; Yu XF
    J Mol Biol; 2008 Jan; 375(4):1098-112. PubMed ID: 18067920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
    Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
    J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
    Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
    PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.
    Tian C; Wang T; Zhang W; Yu XF
    Nucleic Acids Res; 2007; 35(21):7288-302. PubMed ID: 17959647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.
    Zhang W; Du J; Yu K; Wang T; Yong X; Yu XF
    J Virol; 2010 Dec; 84(24):12903-13. PubMed ID: 20926562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z; Zhang W; Chen G; Xu R; Yu XF
    J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
    Wang T; Zhang W; Tian C; Liu B; Yu Y; Ding L; Spearman P; Yu XF
    Virology; 2008 Jul; 377(1):71-9. PubMed ID: 18495196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.
    Song C; Sutton L; Johnson ME; D'Aquila RT; Donahue JP
    J Biol Chem; 2012 May; 287(20):16965-74. PubMed ID: 22451677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores.
    Donahue JP; Levinson RT; Sheehan JH; Sutton L; Taylor HE; Meiler J; D'Aquila RT; Song C
    J Virol; 2015 Feb; 89(4):2415-24. PubMed ID: 25505075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of APOBEC3G binding to 7SL RNA.
    Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
    Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.
    Maeda K; Almofty SA; Singh SK; Eid MMA; Shimoda M; Ikeda T; Koito A; Pham P; Goodman MF; Sakaguchi N
    J Immunol; 2013 Dec; 191(12):6030-6039. PubMed ID: 24198285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
    Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
    J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stably expressed APOBEC3F has negligible antiviral activity.
    Miyagi E; Brown CR; Opi S; Khan M; Goila-Gaur R; Kao S; Walker RC; Hirsch V; Strebel K
    J Virol; 2010 Nov; 84(21):11067-75. PubMed ID: 20702622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.
    Wang X; Li X; Ma J; Zhang L; Ma L; Mi Z; Zhou J; Guo F; Kleiman L; Cen S
    Virus Res; 2014 Oct; 191():30-8. PubMed ID: 25038404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.
    Zhen A; Du J; Zhou X; Xiong Y; Yu XF
    PLoS One; 2012; 7(7):e38771. PubMed ID: 22859935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
    Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
    J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
    Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF
    PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles.
    Didierlaurent L; Racine PJ; Houzet L; Chamontin C; Berkhout B; Mougel M
    Nucleic Acids Res; 2011 Nov; 39(20):8915-27. PubMed ID: 21791531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Acting determinants of 7SL RNA packaging by HIV-1.
    Keene SE; Telesnitsky A
    J Virol; 2012 Aug; 86(15):7934-42. PubMed ID: 22593161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.